Velpatasvir
Name: Velpatasvir
Dosing & Uses
Hepatitis C
Not available as a single agent in the United States
See combination drug monographs for
- Sofosbuvir/velpatasvir
- Sofosbuvir/velpatasvir/voxilaprevir
Safety and efficacy not established
Pharmacology
Pharmacology
Velpatasvir: Pangenotypic HCV NS5A inhibitor; the NS5A protein is required for viral replication
Patient Handout
Print without Office InfoPrint with Office Info